European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

In 2011, the European markets for bone graft substitute, dental membranes and tissue engineering products approached €248 million.
•    Austria,
•    Benelux (comprising Belgium, the Netherlands and Luxemburg),
•    Czech Republic
•    France,
•    Germany,
•    Greece
•    Israel,
•    Italy,
•    Poland
•    Portugal,
•    Romania
•    Scandinavia (comprising Finland, Denmark, Sweden and Norway),
•    Spain,
•    Switzerland,
•    Turkey
•    and the United Kingdom

European Dental Bone Graft Substitutes Market

Published: March 2012
No. of Pages:249
Price: Single User License: US$11495              Corporate User License: 13995
                  

This report also includes the following market segments:
•    Dental Bone Graft Substitute Market
•    Dental Autograft Potential Market
•    Dental Xenograft Market
•    Synthetic Bone Graft Substitute Materials Market
•    Dental Membrane Market

Major points covered in Table of Contents of this report include:
EXECUTIVE SUMMARY 

RESEARCH METHODOLOGY 

EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKETS OVERVIEW

COUNTRY PROFILES

DENTAL BONE GRAFT SUBSTITUTE MARKET 

DENTAL MEMBRANE MARKET 

POTENTIAL MARKETS FOR DENTAL GROWTH FACTORS

APPENDIX: ISRAEL, POLAND, ROMANIA, TURKEY, GREECE AND CZECH REPUBLIC DENTAL BONE RAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET 

ABBREVIATIONS 

Explore reports related to Medical Devices @ http://www.reportsnreports.com/market-research/medical-devices/                              

Manual Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

As the population ages, people are more frail and need assistance for mobility. Hospital and homecare wheelchair technology is evolving to give people with disabilities more mobility. Mobility depends on a wheelchair that is fit to purpose.
Are people going to move themselves? Are they going to be pushed around? Is the wheelchair used for sports? Many issues impact the choice of a wheelchair, including cost and reimbursement availability.

Markets are poised to create the ability for people to get more exercise and impact the healthcare delivery industry by encouraging mobility of people who were previously bed ridden. Wheelchairs impact care delivery, permitting the patient to control mobility for the rehabilitation efforts. Lightweight wheel chairs give patients the ability to control movement.

Transport wheelchairs are used for moving patients from the bed to another place. Patients and family gain more control over the care delivery with the availability of transport wheelchairs. Care can be delivered in familiar settings.

Invacare is an industry leader in the market for manual wheelchairs, power wheelchairs, and home medical products. The leadership position is bolstered by the ability to offer quality products and an enviable distribution network. Invacare is very happy to take care of its distribution network, not competing with it by selling directly. Invacare is very good about supporting the dealers in every way, including helping with financing.

Invacare's manual wheelchairs are for use inside and outside the home, institutional settings, or public places. People who are chronically or temporarily disabled and require basic mobility can buy chairs with no frame modification. Invacare manual wheelchair lines include a range of light weight, ultra-lightweight, and sport product lines. These lines offer wheelchairs that accommodate diverse capabilities and unique needs of the individual from petite to bariatric sizes.

Manual Wheelchair Market to 2018

Published: February 2012
No. of Pages: 365
Price: Single User License – US$3700              Corporate User License – US$7400
                                        


Invacare increased its lead in the wheelchair markets achieving 49% market share in 2011, increasing its share by several percent in the total market as a result of good marketing, execution of sales strategy, and growing revenue while there was a decline in the overall market size.

Sunrise Medical offers the extra lightweight and titanium wheelchairs Quickie 2. The Quickie 2 from Sunrise Medical has features and options. The folding chair has 64,000 configurations to customize the chair. It's versatility and well-established track record has made the Quickie 2 the premier choice of manual folding ultralight wheelchairs for over 25 years.

Standard wheelchair markets are forecast to grow modestly as new materials and more lightweight chairs increase efficiency in hospitals and nursing homes. Units are being manufactured more inexpensively in Asia, providing higher quality as less cost. Modular systems permit efficiencies of scale.

Major points covered in Table of Contents of this report include:
1. LIGHTWEIGHT WHEELCHAIR MARKET DYNAMICS AND MARKET DESCRIPTION

2.MANUAL LIGHTWEIGHT WHEELCHAIR MARKET SHARES AND FORECASTS

3.LIGHTWEIGHT MANUAL WHEELCHAIR PRODUCT DESCRIPTION

4.WHEELCHAIR TECHNOLOGY

5. LIGHTWEIGHT MANUAL WHEELCHAIRS COMPANY PROFILES

List of Tables and Figures

Explore Table of Contents available in the report @ http://www.reportsnreports.com/reports/146929-manual-wheelchair-market-shares-strategies-and-forecasts-worldwide-2012-to-2018.html

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Insulin Delivery Devices Market

Published: January 2012
No. of Pages: 104
Price: Single User License – US$3995              Corporate User License – US$11985
                                     

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the insulin delivery devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.

Explore Comprehensive list of Tables & Figures available in the report @ http://www.reportsnreports.com/reports/144710-insulin-delivery-devices-global-pipeline-analysis-competitive-landscape-and-market-forecasts-to-2017.html.

Cardiac Rhythm Management Devices World Markets

Published: October 2011
No. of Pages: 250
Price: $ 3400


This report reviews the worldwide cardiac rhythm management market size for the U.S., European and Asian markets. Individual country markets such as Japan, the Philippines, Australia, and the Middle East are covered. Important regulatory issues that impact the use of cardiac rhythm devices are explored for countries like the U.S., Japan, Australian, Korea, India, China, Israel, the Philippines, and those in the E.U. Reimbursement strategies for the U.S. Medicare program and European and Japanese medical insurance programs are discussed. Also, a summary of current legal proceedings in this industry, which are often used for competitive purposes, is provided. It focuses sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices. The cardiac rhythm management markets are divided into the segments of: external defibrillators, implantable defibrillators, external pacemakers, implantable pacemakers, and defibrillator and pacemaker electrodes and leads heart failure specialty products.


Browse All: Medical Devices Market Research Reports 

Table Of Contents
1 Executive Summary
1.1 Methodology
1.2 Overview of Report Objectives
2 Medical Device Market Overview
2.1.1 U.S. Medical Device Industry
2.1.2 China
2.1.3 Hong Kong
2.1.4 Taiwan
2.1.5 Singapore
2.1.6 Japan
2.1.7 Canadian Medical Device Market
2.1.8 European Medical Device Market
2.1.9 U.S. Cardiac Rhythm Management Market
2.1.10 European Market
2.1.11 Asian Market
2.1.11.1 Japanese Market Overview
2.1.11.2 Japanese Medical Practice
2.1.11.3 Japanese Distribution/Business Practices
2.1.11.4 Japanese Pricing
2.1.11.5 The Philippines Market
2.1.12 Australian Market
2.1.13 Middle Eastern Market
2.2 Cardiovascular Conditions Treated with Defibrillation and/or Pacing Devices
2.2.1 Cardiac Rhythm Management
2.2.2 Conditions Treated
2.2.2.1 Bradycardia
2.2.2.2 Tachyarrhythmia
2.2.2.3 Heart Failure
2.2.2.4 Atrial Fibrillation
2.3 Principal Products
2.3.1 Implantable Cardiac Rhythm Devices for Bradycardia
2.3.1.1 Single-Chamber Pacemakers
2.3.1.1.1 Non-Rate Responsive Devices
2.3.1.1.2 Rate Responsive Devices
2.3.2 Dual-Chamber Pacemakers
2.3.3 Pacemakers by Manufacturer
2.3.3.1 ELA Medical (Sorin/Sina)
2.3.3.2 Guidant
2.3.3.3 Medtronic
2.3.3.4 St. Jude Medical
2.3.3.5 CCC Del Uruguay SA
2.3.3.6 Fiab Spa (Italy)
2.3.3.7 NeuroCor
2.3.3.8 Pace Medical Inc.
2.3.4 Implantable Cardiac Rhythm Devices for Tachycardia
2.3.4.1 Tachyarrhythmia Devices
2.3.4.2 Biotronik
2.3.4.3 ELA Medical
2.3.4.4 Guidant
2.3.4.5 Medtronic
2.3.4.6 St. Jude Medical
2.3.4.7 Defibrillators Growth Drivers
2.3.4.8 Factors Limiting the Growth of Defibrillators
2.3.5 Implantable Cardiac Rhythm Devices for Heart Failure
2.3.6 External Products
2.3.6.1 Defibrillators
2.3.6.2 Transesophageal Pacing
2.3.7 Product Innovations
2.3.7.1 Miniaturization
2.3.7.2 Modular Designs
2.3.7.3 New Products
2.4 Patient Management
2.5 Regulatory Issues - Government Regulation
2.5.1 U.S. Regulation
2.5.1.1 Importing Medical Devices into the U.S.
2.5.1.2 Exporting Medical Devices from the U.S.
2.5.2 U.K. Regulation
2.5.3 EU Regulation
2.5.4 Japanese Regulation
2.5.5 Australian Regulation
2.5.6 Korea Regulation
2.5.7 India Regulation
2.5.8 Registration for Imported Medical Devices in China
2.5.9 Israel
2.5.10 The Philippines
2.5.11 Overseas Testing to Increase Time-to-Market
2.6 Guidelines and Trade Organizations
2.6.1 American Heart Association (AHA)
2.6.2 Health Industry Manufacturers Association (HIMA)
2.7 Other Factors Influencing Cardiac Rhythm Management Devices
2.8 Worldwide Developments
2.9 Reimbursement
2.9.1 U.S. Reimbursement
2.9.1.1 Category C Codes
2.9.1.2 Medicare Decision on MADIT Reimbursements
2.9.2 European Reimbursement
2.9.3 Japanese Reimbursement
2.10 Legal Proceedings
2.11 Competition
2.12 Strategic Corporate Developments
2.12.1 Acquisitions
2.12.2 Partnerships
2.12.3 Other Developments
2.12.4 Product Launches
3 The External Defibrillator Market
3.1 Defibrillators Overview
3.2 External Automated Defibrillators
3.3 Analysis of Major Competitors
4 The Implantable Defibrillator Market
4.1 Overview
4.1.1 Market Drivers for ICDs
4.2 The Worldwide Market
4.3 The U.S. Market
4.4 Japanese Market
4.5 Analysis of Major Competitors
4.5.1 Biotronik
4.5.2 Guidant Corporation
4.5.3 Medtronic
4.5.4 St. Jude Medical
4.5.5 ELA Medical
4.5.6 Japan Lifeline (JLL)
4.5.7 Cardiac Rhythm Management
5 The External Pacemakers Market
5.1 Overview
5.2 The U.S. Market
5.3 The Worldwide Market
5.4 Analysis of Major Competitors
5.5 Transvenous External Pacemakers
5.6 Transvenous Pacemakers' Development
6 The Implantable Pacemakers Market
6.1 Overview
6.2 The Worldwide Market
6.3 The U.S. Market
6.4 Analysis of Major Competitors
6.5 Transvenous Temporary Pacemakers
7 Market Overview
7.1
7.1.1 Defibrillator and Pacemaker Lead/Electrode Markets
7.1.2 Lead Extraction Market
7.1.3 Electrode Tips and Rings
7.2 The Worldwide Market
7.3 The U.S. Market
7.4 Analysis of Major Competitors
7.4.1 Cardiotronic
7.4.2 Guidant Corporation
7.4.3 Medtronic
7.4.4 St. Jude Medical
7.4.5 Zoll Medical
7.4.6 Biomec
7.4.7 ELA Medical
7.4.8 Sorin Biomedica
7.4.9 Biotronik
7.4.10 DR-ING P Osypka GmbH
7.4.11 CardioDynamics
8 Heart Failure Products
8.1 Overview
8.2 Heart Failure Conditions
8.3 Heart Failure Technology Platforms
8.4 Patient Management through the Internet
9 Company Profiles
9.1 Cardiac Science Inc.
9.2 Ballard Medical Products (Cardiotronic Systems Inc.) Kimberly-Clarke
9.3 Guidant Corporation
9.4 HeartBeat Medical Corporation
9.5 Medtronic Inc.
9.6 Pace Medical Inc.
9.7 St. Jude Medical, Inc.
9.8 Zoll Medical Corporation
9.9 General Electric Corporation Medical Division
9.10 Koninklijke Philips Electronics
9.11 Thoratec Corporation
9.12 Biomec Inc.
9.13 ELA Medical
9.14 Sorin Biomedica/ELA
9.15 Biotronik
9.16 Japan Lifeline
9.17 Cook Vascular Inc.
9.18 Emtel
9.19 Heraeus
9.20 Mayo Healthcare
9.21 VascoMed, GmbH
9.22 Oscor, GmbH
9.23 CardioDynamics International Corp.
9.24 Vermed
10 Industry Trends
11 Corporate Directory
Appendices
Appendix 1: Cardiac Rhythm CPT Codes for Medicare
Appendix 2: New European Guideline for Defibrillator Implants
Appendix 3: Cardiovascular Device Manufacturers Internet Links
Appendix 4: Reimbursement CPT/APC Codes for Pacing Monitors
Appendix 5: Frequently Asked Questions on Transesophageal Cardiology
Appendix 6: Revision of Japanese Medical Device Approval Applications Classifications
Appendix 7: Medical Device Regulatory Requirements for Australia
Appendix 8: Regulation of Medical Devices in China
Appendix 9: Chinese Laboratories Accredited by the State Drug Administration for Product Testing